Investigation on prevalence and risk factors associated with genitourinary syndrome of menopause in middle-aged and older women in Beijing community: a cross sectional study
- PMID: 36585649
- PMCID: PMC9801667
- DOI: 10.1186/s12905-022-02099-w
Investigation on prevalence and risk factors associated with genitourinary syndrome of menopause in middle-aged and older women in Beijing community: a cross sectional study
Abstract
Background: Genitourinary syndrome of menopause (GSM) comprises genital symptoms (dryness, burning, itching, irritation, bleeding), sexual symptoms (dyspareunia and other sexual dysfunctions) and urinary symptoms (dysuria, frequency, urgency, recurrent urinary infections) associated with menopause. To avoid invasive testing and painful physical examinations, validated questionaries, which can assess the prevalence and risk factors associated with symptoms of GSM. We aimed to investigate the prevalence and risk factors associated with GSM in middle-aged and older women in the communities of Beijing, China.
Methods: A cross-sectional, questionnaire study was performed among 35-70 years old Chinese woman. Vaginal health index score and urinary distress inventory (UDI-6) was used to evaluate vulvovaginal atrophy (VVA) and urinary incontinence (UI). Stages of pelvic organ prolapse (POP) was measured during gynecological examination with POP-Q system. Mean ± standard deviation (SD) and proportion/percentages were used to summarize continuous and categorial variables respectively. The Bonferroni method was used to adjust for multiple comparisons.
Results: A total of 2702/3000 participants completed the questionnaire survey. The mean ± SD age of participants was 53.7 ± 7.0 years and prevalence of VVA among participants was 34.8% (941/2702). In UDI-6 questionnaires total 47.5% (1284/2702) participants reported experiencing urinary incontinence (UI). Further, POP was highly prevalent in anterior vaginal wall 38.9% (1050/2702) followed by posterior vaginal wall 25.3% (683/2702) and uterine 22.2% (599/2702). Besides, multiple logistic regression analysis inferred older age (45-54 years [OR (95% CI): 3.38 (2.03, 5.64)]; 55-64 years [OR (95% CI): 8.63 (5.09, 14.64)]), menopause [OR (95% CI): 2.20 (1.71, 2.85)] and Faecal Inconsistence (FI) [OR (95% CI): 1.31(1.00, 1.72)] as independent risk factors for VVA.
Conclusions: Our study evidenced that GSM is prevalent in old age Chinese women. GSM is related with UI, POP and VVA. Further older age, menopause and FI were risk factors associated with VVA. Our findings could help health care personnel to get a comprehensive overview of factors associated with VVA and urinal distress, which may facilitate early detection and prevention of GSM.
Keywords: Genitourinary syndrome of menopause; Pelvic organ prolapse; Risk factor; Urinary incontinence; Vulvovaginal atrophy.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they do not have any conflict of interest.
Similar articles
-
Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.Minerva Ginecol. 2017 Aug;69(4):342-349. doi: 10.23736/S0026-4784.17.04072-2. Minerva Ginecol. 2017. PMID: 28608667
-
Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.Minerva Ginecol. 2016 Jun;68(3):225-36. Minerva Ginecol. 2016. PMID: 27206062
-
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.Front Endocrinol (Lausanne). 2019 Aug 21;10:561. doi: 10.3389/fendo.2019.00561. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31496993 Free PMC article. Review.
-
CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.J Sex Med. 2022 Mar;19(3):452-470. doi: 10.1016/j.jsxm.2021.12.010. Epub 2022 Jan 29. J Sex Med. 2022. PMID: 35101378
-
Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.Climacteric. 2023 Aug;26(4):336-352. doi: 10.1080/13697137.2023.2225766. Epub 2023 Jul 3. Climacteric. 2023. PMID: 37395104 Review.
Cited by
-
The Link Between Menopause and Urinary Incontinence: A Systematic Review.Cureus. 2024 Oct 11;16(10):e71260. doi: 10.7759/cureus.71260. eCollection 2024 Oct. Cureus. 2024. PMID: 39525118 Free PMC article. Review.
-
Scale development and validation of perimenopausal women disability index in the workplace.Environ Health Prev Med. 2024;29:4. doi: 10.1265/ehpm.23-00239. Environ Health Prev Med. 2024. PMID: 38311393 Free PMC article.
-
Effect of Vitamin D on the Proliferation and Barrier of Atrophic Vaginal Epithelial Cells.Molecules. 2023 Sep 13;28(18):6605. doi: 10.3390/molecules28186605. Molecules. 2023. PMID: 37764381 Free PMC article.
References
-
- Age at natural menopause and associated factors in adult women: Findings from the China Kadoorie Biobank study in Zhejiang rural area - PubMed. https://pubmed.ncbi.nlm.nih.gov/29668705/. Accessed 19 Sep 2022. - PMC - PubMed
-
- Chuni N, Sreeramareddy CT. Frequency of symptoms, determinants of severe symptoms, validity of and cut-off score for menopause rating scale (MRS) as a screening tool: a cross-sectional survey among midlife Nepalese women. BMC Womens Health. 2011;11:30. doi: 10.1186/1472-6874-11-30. - DOI - PMC - PubMed
-
- Portman DJ, Gass MLS. Vulvovaginal atrophy terminology consensus conference panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International society for the study of women’s sexual health and the North American menopause society. Menopause N Y N. 2014;21:1063–1068. doi: 10.1097/GME.0000000000000329. - DOI - PubMed
-
- Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women - PubMed. https://pubmed.ncbi.nlm.nih.gov/31496993/. Accessed 19 Sep 2022. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical